Related Experiment Video
Updated: Jun 23, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Congestive heart failure and renal complications
Valentin J Del Rio-Santiago1, Luis Rodriguez-Ospina, Héctor R Córdova
1Cardiology Section, Department of Medicine, VA Caribbean Healthcare System, Puerto Rico, USA.
Boletin De La Asociacion Medica De Puerto Rico
|April 30, 2009
Summary
Congestive heart failure (CHF) is a major cause of hospitalization and death, especially in older adults. This review explores CHF management, focusing on novel non-pharmacologic treatments for acute decompensated heart failure.
Area of Science:
- Cardiology
- Nephrology
- Geriatrics
Background:
- Congestive heart failure (CHF) is the primary cause of hospital admissions for individuals over 65.
- CHF is a leading cause of heart-related mortality globally.
- The prevalence of coexisting heart failure and renal dysfunction is significant, particularly in the Western Hemisphere.
Purpose of the Study:
- To review the pathophysiology of congestive heart failure, including edema formation and volume homeostasis.
- To discuss the complex interplay between cardiac and renal systems (cardio-renal syndrome).
- To explore neuroendocrine pathways involved in heart failure and highlight novel non-pharmacologic management strategies for acute decompensated heart failure.
Main Methods:
- This clinical review synthesizes current literature on congestive heart failure.
- It examines pharmacologic and non-pharmacologic treatment modalities.
- Emphasis is placed on ultrafiltration as a novel non-pharmacologic approach.
Main Results:
- Edema formation, volume homeostasis, cardio-renal syndrome, and neuroendocrine pathways are key aspects of CHF.
- Pharmacologic treatments primarily target the neuroendocrine axis.
- Novel non-pharmacologic approaches, such as ultrafiltration, offer new avenues for managing acute decompensated heart failure.
Conclusions:
- Understanding the mechanisms of CHF, including fluid balance and cardio-renal interactions, is crucial.
- Non-pharmacologic interventions like ultrafiltration represent a significant advancement in managing acute decompensated heart failure.
- Further research into integrated management strategies for patients with coexisting heart and kidney dysfunction is warranted.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...